Caplin Point Laboratories Ltd
NSE:CAPLIPOINT

Watchlist Manager
Caplin Point Laboratories Ltd Logo
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Watchlist
Price: 1 951.5 INR -0.13%
Market Cap: 148.3B INR
Have any thoughts about
Caplin Point Laboratories Ltd?
Write Note

Caplin Point Laboratories Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Caplin Point Laboratories Ltd
Accounts Payable Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Accounts Payable
â‚ą2.1B
CAGR 3-Years
33%
CAGR 5-Years
28%
CAGR 10-Years
21%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Accounts Payable
â‚ą26.1B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Accounts Payable
â‚ą26.8B
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Accounts Payable
â‚ą57.3B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
13%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Accounts Payable
â‚ą21.9B
CAGR 3-Years
7%
CAGR 5-Years
2%
CAGR 10-Years
2%
M
Mankind Pharma Ltd
NSE:MANKIND
Accounts Payable
â‚ą11B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Caplin Point Laboratories Ltd's Accounts Payable?
Accounts Payable
2.1B INR

Based on the financial report for Jun 30, 2024, Caplin Point Laboratories Ltd's Accounts Payable amounts to 2.1B INR.

What is Caplin Point Laboratories Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
21%

Over the last year, the Accounts Payable growth was 27%. The average annual Accounts Payable growth rates for Caplin Point Laboratories Ltd have been 33% over the past three years , 28% over the past five years , and 21% over the past ten years .

Back to Top